These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 16720250

  • 1. Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand.
    Kumar JS, Prabhakaran J, Erlandsson K, Majo VJ, Simpson NR, Pratap M, Van Heertum RL, Mann JJ, Parsey RV.
    Nucl Med Biol; 2006 May; 33(4):565-74. PubMed ID: 16720250
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and in vivo evaluation of [O-methyl-11C] N-[3,5-dichloro-2-(methoxy)phenyl]-4-(methoxy)-3-(1-piperazinyl)benzenesulfonamide as an imaging probe for 5-HT6 receptors.
    Liu F, Majo VJ, Prabhakaran J, Milak MS, John Mann J, Parsey RV, Kumar JS.
    Bioorg Med Chem; 2011 Sep 01; 19(17):5255-9. PubMed ID: 21821420
    [Abstract] [Full Text] [Related]

  • 3. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
    Zhu Z, Guo N, Narendran R, Erritzoe D, Ekelund J, Hwang DR, Bae SA, Laruelle M, Huang Y.
    Nucl Med Biol; 2004 Nov 01; 31(8):983-94. PubMed ID: 15607480
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of two potential NK1-receptor ligands using [1-11C]ethyl iodide and [1-11C]propyl iodide and initial PET-imaging.
    Syvänen S, Eriksson J, Genchel T, Lindhe O, Antoni G, Långström B.
    BMC Med Imaging; 2007 Jul 30; 7():6. PubMed ID: 17663770
    [Abstract] [Full Text] [Related]

  • 5. 11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.
    Talbot PS, Narendran R, Butelman ER, Huang Y, Ngo K, Slifstein M, Martinez D, Laruelle M, Hwang DR.
    J Nucl Med; 2005 Mar 30; 46(3):484-94. PubMed ID: 15750163
    [Abstract] [Full Text] [Related]

  • 6. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
    Huang Y, Hwang DR, Bae SA, Sudo Y, Guo N, Zhu Z, Narendran R, Laruelle M.
    Nucl Med Biol; 2004 Jul 30; 31(5):543-56. PubMed ID: 15219271
    [Abstract] [Full Text] [Related]

  • 7. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M, Stoffel A, Kessler LJ, Schubiger PA, Ametamey SM.
    Nucl Med Biol; 2007 Nov 30; 34(8):973-80. PubMed ID: 17998101
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S, Xue B, Collins D, Pichika R, Bagnera R, Leslie FM, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J.
    J Nucl Med; 2005 Jan 30; 46(1):130-40. PubMed ID: 15632043
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates.
    Kumar JS, Prabhakaran J, Majo VJ, Milak MS, Hsiung SC, Tamir H, Simpson NR, Van Heertum RL, Mann JJ, Parsey RV.
    Eur J Nucl Med Mol Imaging; 2007 Jul 30; 34(7):1050-60. PubMed ID: 17221184
    [Abstract] [Full Text] [Related]

  • 10. 123I-MSP and F[11C]MSP: new selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in mice.
    Samnick S, Remy N, Ametamey S, Bader JB, Brandau W, Kirsch CM.
    Life Sci; 1998 Jul 30; 63(22):2001-13. PubMed ID: 9839544
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and evaluation of vesamicol analog (-)-O-[11C]methylvesamicol as a PET ligand for vesicular acetylcholine transporter.
    Kawamura K, Shiba K, Tsukada H, Nishiyama S, Mori H, Ishiwata K.
    Ann Nucl Med; 2006 Jul 30; 20(6):417-24. PubMed ID: 16922470
    [Abstract] [Full Text] [Related]

  • 12. Radiosynthesis and ex vivo evaluation of [11C]-SIB-1553A as a PET radiotracer for beta4 selective subtype nicotinic acetylcholine receptor.
    Sobrio F, Quentin T, Dhilly M, Bourdier T, Tymciu S, Debruyne D, Barré L.
    Nucl Med Biol; 2008 Apr 30; 35(3):377-85. PubMed ID: 18355694
    [Abstract] [Full Text] [Related]

  • 13. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
    Hansen HD, Herth MM, Ettrup A, Andersen VL, Lehel S, Dyssegaard A, Kristensen JL, Knudsen GM.
    J Nucl Med; 2014 Apr 30; 55(4):640-6. PubMed ID: 24566002
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
    de Vries EF, Kortekaas R, van Waarde A, Dijkstra D, Elsinga PH, Vaalburg W.
    J Nucl Med; 2005 Aug 30; 46(8):1384-92. PubMed ID: 16085598
    [Abstract] [Full Text] [Related]

  • 15. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA).
    Huang Y, Narendran R, Bae SA, Erritzoe D, Guo N, Zhu Z, Hwang DR, Laruelle M.
    Nucl Med Biol; 2004 Aug 30; 31(6):727-38. PubMed ID: 15246363
    [Abstract] [Full Text] [Related]

  • 16. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907.
    Ito H, Nyberg S, Halldin C, Lundkvist C, Farde L.
    J Nucl Med; 1998 Jan 30; 39(1):208-14. PubMed ID: 9443763
    [Abstract] [Full Text] [Related]

  • 17. Effects of R-102444 and its active metabolite R-96544, selective 5-HT2A receptor antagonists, on experimental acute and chronic pancreatitis: Additional evidence for possible involvement of 5-HT2A receptors in the development of experimental pancreatitis.
    Ogawa T, Sugidachi A, Tanaka N, Fujimoto K, Fukushige J, Tani Y, Asai F.
    Eur J Pharmacol; 2005 Oct 03; 521(1-3):156-63. PubMed ID: 16183055
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
    Jarkas N, McConathy J, Votaw JR, Voll RJ, Malveaux E, Camp VM, Williams L, Goodman RR, Kilts CD, Goodman MM.
    Nucl Med Biol; 2005 Jan 03; 32(1):75-86. PubMed ID: 15691664
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alpha7 nicotinic cholinergic agonist drug.
    Kim SW, Ding YS, Alexoff D, Patel V, Logan J, Lin KS, Shea C, Muench L, Xu Y, Carter P, King P, Constanzo JR, Ciaccio JA, Fowler JS.
    Nucl Med Biol; 2007 Jul 03; 34(5):541-51. PubMed ID: 17591554
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
    Gao M, Mock BH, Hutchins GD, Zheng QH.
    Nucl Med Biol; 2005 Jul 03; 32(5):543-52. PubMed ID: 15982585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.